Everolimus 49884-0160-02
- Manufacturer
- Par Health Usa, Llc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- December 16, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA205775
Need to source Everolimus? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Everolimus | .75 mg/1 |
Drug Class
Kinase Inhibitor [EPC]mTOR Inhibitor Immunosuppressant [EPC]Cytochrome P450 2D6 Inhibitors [MoA]
Selected Package
49884-0160-02Selected6 BLISTER PACK in 1 CARTON (49884-160-02) / 10 TABLET in 1 BLISTER PACK (49884-160-52)